H6PD and injury: Upon treatment with candesartan, an AT1 receptor (AT1R) antagonist with benefits in this specific traumatic brain injury model, the expression of the genes for both G6PDH and 6PGNDH did not change, suggesting that the injury-induced increase in the expression of these genes (measured in the hippocampus) is protective [42].